ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors
  • Partners

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2026 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Monobasic Sodium Phosphate Monohydrate

Also known as: Monobasic Sodium Phosphate Monohydrate, Sodium dihydrogen phosphate monohydrate, Monosodium phosphate monohydrate, Sodium phosphate monobasic monohydrate

Overview

Sodium phosphate monobasic monohydrate (NaH2PO4·H2O) is a synthetic crystalline salt, chemically identical to phosphate salts found naturally in biological systems. It is widely utilized across various industries, primarily as a buffering agent, emulsifier, and sequestrant in food products, and significantly as a pharmaceutical excipient. Its most prominent medical application is as an osmotic laxative for bowel preparation prior to colonoscopy. This compound is a white granular powder, highly soluble in water, and exhibits an acidic pH. Its established use in clinical settings, particularly for bowel cleansing, is supported by a substantial body of research, including numerous randomized controlled trials and meta-analyses, confirming its efficacy and safety profile under controlled conditions.

Benefits

Monobasic sodium phosphate monohydrate is primarily beneficial as an effective bowel cleansing agent for colonoscopy preparation. A meta-analysis of 13 randomized controlled trials (n=2773) demonstrated that sodium phosphate tablets are as effective as polyethylene glycol (PEG) solutions in achieving adequate bowel cleansing (RR 1.02, 95% CI 0.96-1.08, p=0.46). Furthermore, it offers superior patient tolerance, with lower incidence of nausea (RR 0.67, 95% CI 0.58-0.76, p<0.00001), higher taste ratings (RR 1.33, 95% CI 1.26-1.40, p<0.00001), and increased willingness to repeat the treatment (RR 1.52, 95% CI 1.28-1.80, p<0.00001). While effective, it causes more significant electrolyte shifts, including decreases in serum potassium and calcium, and increases in serum phosphorus, compared to PEG. Its rapid onset of cathartic effect within hours makes it clinically significant for pre-procedural use, primarily in adults undergoing colonoscopy.

How it works

Monobasic sodium phosphate monohydrate functions as an osmotic laxative. Upon ingestion, the phosphate ions are poorly absorbed and remain in the intestinal lumen. This creates an osmotic gradient, drawing water from the body's tissues into the bowel lumen. The increased fluid volume distends the colon, stimulating peristalsis and promoting rapid bowel evacuation. While its primary action is localized to the gastrointestinal tract, partial systemic absorption of phosphate ions can occur. This transient absorption can lead to temporary alterations in serum electrolyte balance, specifically hyperphosphatemia and hypocalcemia, which are important considerations for patient safety.

Side effects

While generally safe for bowel preparation in healthy adults, monobasic sodium phosphate monohydrate carries risks of electrolyte disturbances and, rarely, kidney injury. Common side effects, affecting over 5% of users, include nausea, abdominal cramping, and transient electrolyte imbalances. Less common effects (1-5%) include vomiting, dehydration, and dizziness. A rare but serious side effect (<1%) is acute phosphate nephropathy (kidney injury), particularly in individuals with pre-existing renal dysfunction or dehydration. It interacts adversely with medications affecting renal function or electrolyte balance, such as diuretics and ACE inhibitors. Contraindications include severe renal impairment, congestive heart failure, pre-existing electrolyte abnormalities, and bowel obstruction. Caution is advised for elderly patients, those with kidney disease, and individuals on nephrotoxic drugs, due to increased susceptibility to adverse effects.

Dosage

For bowel preparation, the typical dosage involves 45 mL of oral sodium phosphate solution or an equivalent dose in tablet form. This is generally administered in a split-dose regimen, with two administrations spaced several hours apart, usually 6-12 hours before the scheduled colonoscopy. The maximum safe dose is limited by the risk of significant electrolyte disturbances and potential kidney injury; therefore, strict adherence to clinical guidelines for bowel preparation is essential. While both oral solution and tablets are available, tablets are often preferred due to better taste and patient tolerance. Adequate fluid intake is a critical cofactor, as proper hydration is necessary to mitigate the risks of dehydration and severe electrolyte imbalances associated with its osmotic action.

FAQs

Is it safe for kidney patients?

No, it is generally contraindicated or used with extreme caution in kidney patients due to a significant risk of acute phosphate nephropathy and severe electrolyte imbalances.

Can it be used repeatedly?

Repeated use is not recommended without strict medical supervision due to the cumulative risk of electrolyte disturbances and potential kidney damage.

How fast does it work?

It typically induces bowel movements within 1 to 6 hours after administration, making it effective for rapid bowel evacuation.

Does it cause dehydration?

Yes, it can cause dehydration if adequate fluid intake is not maintained during the preparation process, due to its osmotic action.

Is it better than PEG?

It offers comparable bowel cleansing efficacy with better taste and patient tolerance than PEG, but carries a higher risk of significant electrolyte shifts.

Research Sources

  • https://pubmed.ncbi.nlm.nih.gov/37305114/ – This meta-analysis of 13 RCTs (n=2773) compared sodium phosphate tablets to PEG for bowel preparation. It found sodium phosphate to be equally effective for cleansing but superior in patient tolerance (less nausea, better taste, higher willingness to repeat), despite causing greater electrolyte changes. The study highlights the trade-off between patient comfort and electrolyte risk.
  • https://www.ncbi.nlm.nih.gov/books/NBK78241/ – This source discusses the potential association between oral sodium phosphate and kidney injury, particularly acute phosphate nephropathy. It emphasizes the importance of patient selection and hydration to mitigate risks, especially in vulnerable populations such as those with pre-existing renal dysfunction.

Recommended Articles

Best Creatine Types & Optimal Doses Explained

Best Creatine Types & Optimal Doses Explained

Creatine monohydrate is the most effective form, with a recommended dose of 3-5 grams daily for enhanced performance and muscle growth.

Cycling Supplements: What to Cycle & Why

Cycling Supplements: What to Cycle & Why

Cycling supplements is crucial for efficacy and safety, particularly with nootropics and performance enhancers.

Top Recovery Ingredients for Post-Workout

Top Recovery Ingredients for Post-Workout

Optimal recovery post-workout is supported by proteins, carbs, and specific nutrients, tailored to individual needs.

Top Muscle-Building Ingredients Explained

Top Muscle-Building Ingredients Explained

Protein, vitamins, minerals, carbohydrates, healthy fats, and certain supplements are crucial for muscle building.